Market open

Acumen Pharmaceuticals/$ABOS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Acumen Pharmaceuticals

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Ticker

$ABOS
Trading on

Industry

Biotechnology

Employees

61

ISIN

US00509G2093

ABOS Metrics

BasicAdvanced
$61M
-
-$1.93
0.09
-
$61M
0.09
$3.92
$0.86
224K
8.022
7.758
19.06
19.06
-30.95%
-31.31%
-55.68%
0.39
0.39
-0.593
84.05%
-11.13%

What the Analysts think about ABOS

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Acumen Pharmaceuticals stock.

ABOS Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ABOS Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ABOS

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Acumen Pharmaceuticals stock?

What is the P/E ratio for Acumen Pharmaceuticals stock?

Does Acumen Pharmaceuticals stock pay dividends?

When is the next Acumen Pharmaceuticals dividend payment date?

What is the beta indicator for Acumen Pharmaceuticals?